Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Qianhai Health HoldingsHKSE:00911 39 Days Inventory is 50.09 as of Dec. 2025, which is 69% below its 10-year median of 163.21. GuruFocus rates HKSE:00911 with a GF Score™ of 39/100 and a GF Value™ of HK$0.22 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 919 Drug Manufacturers companies, Qianhai Health Holdings ranks better than 89.66% on this metric.
The historical rank and industry rank for Qianhai Health Holdings's Days Inventory or its related term are showing as below:
HKSE:00911'
s Days Inventory Range Over the Past 10 Years
Min: 68.03 Med: 163.21 Max: 533.43
Current: 68.54
During the past 13 years, Qianhai Health Holdings's highest Days Inventory was 533.43. The lowest was 68.03. And the median was 163.21.
HKSE:00911's Days Inventory is ranked better than 89.66% of 919
companies
in the Drug Manufacturers industry
Industry Median: 164.87
vs HKSE:00911: 68.54
Qianhai Health Holdings's Days Inventory
declined
from Dec. 2024 (227.78) to Dec. 2025 (50.09).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Qianhai Health Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 was 3.64.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Qianhai Health Holdings's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.27.
Qianhai Health Holdings (HKSE:00911) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Qianhai Health Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Qianhai Health Holdings's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Qianhai Health Holdings Days Inventory Related Terms
Qianhai Health Holdings Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Qianhai Health Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qianhai Health Holdings Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Qianhai Health Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Qianhai Health Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qianhai Health Holdings (HKSE:00911) has a Days Inventory of 50.09 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Qianhai Health Holdings and its competitors. This is 69% below median its historical median of 163.21. Over the past decade, Qianhai Health Holdings' Days Inventory has ranged from 68.03 to 533.43. According to the industry distribution chart, Qianhai Health Holdings ranks #95 out of 919 companies in the Drug Manufacturers industry, placing it in the top 10.3%.
Is Qianhai Health Holdings' Days Inventory too high?
Qianhai Health Holdings' current Days Inventory of 50.09 is 69% below median its 10-year median of 163.21. Over the past 10 years, this metric has ranged from a low of 68.03 to a high of 533.43. The Drug Manufacturers industry median Days Inventory is 164.87. Qianhai Health Holdings' value of 50.09 is 69.6% below this industry median. Based on the distribution chart, Qianhai Health Holdings ranks #95 out of 919 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Qianhai Health Holdings has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Qianhai Health Holdings' Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Qianhai Health Holdings ranks #95 out of 919 companies for Days Inventory. This places Qianhai Health Holdings in the top 10% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.87. Qianhai Health Holdings' value of 50.09 is 69.6% below this benchmark. Historically, Qianhai Health Holdings' own Days Inventory has ranged from 68.03 to 533.43 over the past decade. While the company's 10-year median is 163.21 vs. the industry median of 164.87, Qianhai Health Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.87, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Qianhai Health Holdings's current Days Inventory of 50.09 is 69.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Qianhai Health Holdings and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qianhai Health Holdings's current Days Inventory is 50.09, which is 69% below median its own 10-year median of 163.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qianhai Health Holdings stock overvalued right now?
Based on GuruFocus' analysis, Qianhai Health Holdings (HKSE:00911) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.22, compared to a current price of HK$0.60 — trading 172.7% above its estimated fair value. The current Days Inventory is 50.09, which is 69% below median its 10-year median of 163.21 and 69.6% below the Drug Manufacturers industry median of 164.87. Qianhai Health Holdings' overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Qianhai Health Holdings (HKSE:00911), the current Days Inventory is 50.09 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qianhai Health Holdings (HKSE:00911) Overvalued in 2026?
Based on GuruFocus' analysis, Qianhai Health Holdings stock appears to be overvalued.
The current stock price of HK$0.60 is trading 172.7% above its estimated GF Value™ of HK$0.22.
GuruFocus considers Qianhai Health Holdings to be Significantly Overvalued.
Key valuation signals for HKSE:00911:
Days Inventory: 50.09 (69% below median its 10-year median of 163.21)
GF Value™: HK$0.22 vs. price of HK$0.60 (172.7% above fair value)
Industry Position: 69.6% below the Drug Manufacturers median (#95 of 919)
No single metric tells the full story. See the HKSE:00911 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qianhai Health Holdings Ltd principally engaged in the sale of health products and electronic component products. It includes Chinese herbal medicines, skin-care and other healthcare products, and the sale of information technology components. The operating segments of the group are Healthcare products and Electronic component products. Healthcare products include the sale of healthcare products, including Chinese herbal medicines, skincare, and other healthcare products. Electronic component products include the sale of information technology components products including central processing units and semiconductors. The group's revenue is all derived from Hong Kong.
39GF Score
Get the complete analysis for HKSE:00911
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00911 has been successfully added to your 
